MDA Breakout Stocks Week 10 - March 2023: High-Frequency Gainers To Give You An EdgeSeeking Alpha • 03/05/23
Merck and AstraZeneca Provide Update on US Regulatory Review of LYNPARZA® (olaparib) for Use in Combination With Abiraterone and Prednisone or Prednisolone for the Treatment of Metastatic Castration-Resistant Prostate CancerBusiness Wire • 03/02/23
Merck Announces Phase 3 KEYNOTE-671 Trial Met Primary Endpoint of Event-Free Survival (EFS) in Patients With Resectable Stage II, IIIA or IIIB Non-Small Cell Lung CancerBusiness Wire • 03/01/23
MDA Breakout Stocks Week 9 - March 2023: High-Frequency Gainers To Give You An EdgeSeeking Alpha • 02/26/23
Merck and Ridgeback Biotherapeutics to appeal advisory panel to EU regulator's decision to recommend refusing authorization of their COVID antiviralMarket Watch • 02/24/23
Merck and Ridgeback Provide Update on EU Marketing Authorization Application for LAGEVRIO™ (Molnupiravir)Business Wire • 02/24/23
Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination With KEYTRUDA(R) (pembrolizumab), was Granted Breakthrough Therapy Designation by the FDA for Adjuvant Treatment of Patients With High-Risk MelaAccesswire • 02/22/23
Grid Therapeutics Initiates a Phase 2 Investigator-Sponsored Trial of GT103 in Combination with Merck's Pembrolizumab in Patients with Advanced Stage Non-Small Cell Lung CancerBusiness Wire • 02/22/23
Dividend Lovers Bet Big on 6 Goldman Sachs Top Conviction List Picks for 202324/7 Wall Street • 02/22/23
Merck Opens Enrollment in New Phase 3 Clinical Trials with Investigational Once-Daily Islatravir in Combination with Doravirine for Treatment of HIV-1 InfectionBusiness Wire • 02/22/23
Merck to Present New Data for Sotatercept and MK-0616 at ACC.23/WCC, Demonstrating Significant Progress in Advancing Its Innovative Cardiovascular PipelineBusiness Wire • 02/21/23
Merck Provides Update on Phase 3 MOVe-AHEAD Trial Evaluating LAGEVRIO™ (molnupiravir) for Post-exposure Prophylaxis for Prevention of COVID-19Business Wire • 02/21/23
MDA Breakout Stocks Week 8 - February 2023: High-Frequency Gainers To Give You An EdgeSeeking Alpha • 02/20/23